ARCHIVES

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

Proflavine Bioassay Ineffective, NCI Says

July 15, 1977

Gallo, Collaborators Map Entire Genetic Structure Of HTLV-III

January 25, 1985

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

January 15, 2010

Drugs and Targets: Cyramza approved in metastatic stomach cancer

November 7, 2014

AACI Committee Makes Case For Clinical Research In Centers; Cancer Control, Group Funds Eyed

December 8, 1978

Broder Sworn In, Cites Three ‘Teachers’ – Gallo, Waldermann, DeVita

January 27, 1989